BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monti JM, Jantos H, Schechter LE. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat. Behav Brain Res 2013;249:65-74. [PMID: 23624323 DOI: 10.1016/j.bbr.2013.04.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang YX, Yang M, Liang F, Li SQ, Yang JS, Huo FQ, Yan CX. The pronociceptive role of 5-HT6 receptors in ventrolateral orbital cortex in a rat formalin test model. Neurochem Int 2019;131:104562. [PMID: 31580911 DOI: 10.1016/j.neuint.2019.104562] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Taciak PP, Lysenko N, Mazurek AP. Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression. Pharmacological Reports 2018;70:37-46. [DOI: 10.1016/j.pharep.2017.07.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
3 de Jong IE, Mørk A. Antagonism of the 5-HT 6 receptor – Preclinical rationale for the treatment of Alzheimer's disease. Neuropharmacology 2017;125:50-63. [DOI: 10.1016/j.neuropharm.2017.07.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 7.6] [Reference Citation Analysis]
4 Brouard JT, Schweimer JV, Houlton R, Burnham KE, Quérée P, Sharp T. Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo. ACS Chem Neurosci 2015;6:1241-7. [PMID: 25837696 DOI: 10.1021/acschemneuro.5b00061] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
5 Kalmbach DA, Schneider LD, Cheung J, Bertrand SJ, Kariharan T, Pack AI, Gehrman PR. Genetic Basis of Chronotype in Humans: Insights From Three Landmark GWAS. Sleep 2017;40. [PMID: 28364486 DOI: 10.1093/sleep/zsw048] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 13.6] [Reference Citation Analysis]
6 Wu Y, Wang L, Yang F, Xi W. Neural Circuits for Sleep-Wake Regulation. Adv Exp Med Biol 2020;1284:91-112. [PMID: 32852742 DOI: 10.1007/978-981-15-7086-5_8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Leiser SC, Iglesias-Bregna D, Westrich L, Pehrson AL, Sanchez C. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism. J Psychopharmacol 2015;29:1092-105. [PMID: 26174134 DOI: 10.1177/0269881115592347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev 2021;73:310-520. [PMID: 33370241 DOI: 10.1124/pr.118.015552] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
9 Wicke K, Haupt A, Bespalov A. Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer’s disease. Expert Opinion on Investigational Drugs 2015;24:1515-28. [DOI: 10.1517/13543784.2015.1102884] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
10 Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C. Therapeutic Potential of 5-HT6 Receptor Agonists. J Med Chem 2015;58:7901-12. [PMID: 26099069 DOI: 10.1021/acs.jmedchem.5b00179] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
11 Helboe L, Egebjerg J, de Jong IE. Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study. Neuroscience 2015;310:442-54. [PMID: 26424380 DOI: 10.1016/j.neuroscience.2015.09.064] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
12 Amat-foraster M, Leiser SC, Herrik KF, Richard N, Agerskov C, Bundgaard C, Bastlund JF, de Jong IE. The 5-HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep-wake architecture. Neuropharmacology 2017;113:45-59. [DOI: 10.1016/j.neuropharm.2016.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
13 de Assis Brasil ES, Guerino Furini CR, da Silva Rodrigues F, Nachtigall EG, Kielbovicz Behling JA, Saenger BF, Farias CP, de Carvalho Myskiw J, Izquierdo I. The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory. Behavioural Brain Research 2019;372:112055. [DOI: 10.1016/j.bbr.2019.112055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lane JM, Vlasac I, Anderson SG, Kyle SD, Dixon WG, Bechtold DA, Gill S, Little MA, Luik A, Loudon A, Emsley R, Scheer FA, Lawlor DA, Redline S, Ray DW, Rutter MK, Saxena R. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat Commun 2016;7:10889. [PMID: 26955885 DOI: 10.1038/ncomms10889] [Cited by in Crossref: 146] [Cited by in F6Publishing: 133] [Article Influence: 24.3] [Reference Citation Analysis]
15 Pineda-farias JB, Barragán-iglesias P, Valdivieso-sánchez A, Rodríguez-silverio J, Flores-murrieta FJ, Granados-soto V, Rocha-gonzález HI. Spinal 5-HT 4 and 5-HT 6 receptors contribute to the maintenance of neuropathic pain in rats. Pharmacological Reports 2017;69:916-23. [DOI: 10.1016/j.pharep.2017.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]